ORPHA:2248
Hypoplastic left heart syndrome
Synonyms: HLHS
- Type
- Morphological anomaly
- Group
- Disorder
- Inheritance
- Unknown
- Age of onset
- Antenatal, Neonatal
- Status
- active
A rare, congenital, non-syndromic, heart malformation characterized by under development of the left-sided cardiac structures (including left ventricle, ascending aorta, aortic arch, and mitral and/or aortic valve) such that the left heart is unable to provide adequate systemic cardiac output.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Hypoplastic left heart syndrome | HLHS |
| fr | Hypoplasie du coeur gauche | = en |
| de | Hypoplastisches Linksherzsyndrom | = en |
| es | Síndrome del corazón izquierdo hipoplásico | |
| it | Sindrome del cuore ipoplasico | = en |
| nl | Hypoplastisch linkerhartsyndroom | = en |
| pt | Síndrome de coração esquerdo hipoplástico | |
| pl | Zespół hipoplazji lewego serca | = en |
| cs | Syndrom hypoplázie levého srdce | = en |
| uk | Синдром гіпоплазії лівих відділів серця | = en |
| zh | 左心发育不良综合征 | = en |
| tr | Hipoplastik sol kalp sendromu | = en |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 241550 | E | validated | |
| OMIM | 614435 | BTNT | validated | |
| ICD-10 | Q23.4 | E | specific | validated |
| ICD-11 | LA89.3 | E | specific | validated |
| MONDO | 0004933 | E | validated | |
| MeSH | D018636 | E | validated | |
| UMLS | C0152101 | E | validated | |
| GARD | 6739 | E | validated | |
| MedDRA | 10021076 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:95483Univentricular cardiopathy
rare developmental anomalies during embryogenesis; rare cardiac malformations
No children.
4
Genes
2 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| GJA1 | Major susceptibility factor in | Assessed | HGNC:4274 | ENSG00000152661 | 121014 | 6q22.31 | gap junction protein alpha 1 | 11470490[PMID]_19683641[PMID]_19298922[PMID] |
| NKX2-5 | Major susceptibility factor in | Assessed | HGNC:2488 | ENSG00000183072 | 600584 | 5q35.1 | NK2 homeobox 5 | 12798584[PMID]_14607454[PMID]_20456451[PMID] |
5
Prevalence and incidence
24 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 5.5 / 100 000 | Portugal | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2009[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 12.5 / 100 000 | Switzerland | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2009[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 16.6 / 100 000 | United Kingdom | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 22.3 / 100 000 | Ukraine | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-9 / 100 000 | 1.9 / 100 000 | Spain | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Point prevalence | Unknown | — | Worldwide | Class only | Not yet validated | ORPHANET |
| Prevalence at birth | 1-5 / 10 000 | 18 / 100 000 | Worldwide | Value and class | Not yet validated | 27409588[PMID]_30661430[PMID]_2339046[PMID]_ORPHANET |
| Prevalence at birth | 1-5 / 10 000 | 16.2 / 100 000 | United States | Value and class | Validated | 2339046[PMID] |
| Prevalence at birth | 1-5 / 10 000 | 15.1 / 100 000 | Europe | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 49.1 / 100 000 | Austria | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2009[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 29.1 / 100 000 | Belgium | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 56.8 / 100 000 | Croatia | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 21.3 / 100 000 | Denmark | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 11.8 / 100 000 | France | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 23.8 / 100 000 | Germany | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 19.9 / 100 000 | Hungary | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 18.1 / 100 000 | Ireland | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-9 / 100 000 | 9.9 / 100 000 | Italy | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 49.8 / 100 000 | Malta | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Prevalence at birth | 1-9 / 100 000 | 5.8 / 100 000 | Netherlands | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-5 / 10 000 | 16.4 / 100 000 | Norway | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2011[OTHER] |
| Prevalence at birth | 1-9 / 100 000 | 9.2 / 100 000 | Poland | Value and class | Validated | EUROCAT European surveillance of congenital anomalies 2010[OTHER] |
| Prevalence at birth | 1-9 / 100 000 | 8 / 100 000 | China | Value and class | Validated | 27409588[PMID] |
| Prevalence at birth | 1-5 / 10 000 | 11.6 / 100 000 | Sweden | Value and class | Validated | 30661430[PMID] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
8 annotations · validated 2016-06-01| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0004383 | Hypoplastic left heart | |
| Frequent (79-30%) | ||
| HP:0012304 | Hypoplastic aortic arch | |
| Occasional (29-5%) | ||
| HP:0002916 | Abnormality of chromosome segregation | |
| HP:0001631 | Atrial septal defect | |
| HP:0009800 | Maternal diabetes | |
| HP:0011560 | Mitral atresia | |
| HP:0001718 | Mitral stenosis | |
| HP:0001643 | Patent ductus arteriosus | |
Run the differential on the 1 obligate / very frequent terms
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/2248
- This record as JSON: /data/d/2248.json